|
481 |
Towards achieving semantic interoperability of clinical study data with FHIR
Enthalten in Journal of biomedical semantics Bd. 8, 19.9.2017, Nr. 1, date:12.2017: 1-14
|
|
|
|
482 |
Tracking implementation strategies: a description of a practical approach and early findings
Enthalten in Health research policy and systems Bd. 15, 23.2.2017, Nr. 1, date:12.2017: 1-12
|
|
|
|
483 |
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women
Enthalten in BMC medicine Bd. 15, 3.4.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
484 |
Treatment with L-citrulline in patients with post-polio syndrome: study protocol for a single-center, randomised, placebo-controlled, double-blind trial
Enthalten in Trials Bd. 18, 9.3.2017, Nr. 1, date:12.2017: 1-9
|
|
|
|
485 |
Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy
Enthalten in BMC neurology Bd. 17, 11.9.2017, Nr. 1, date:12.2017: 1-12
|
|
|
|
486 |
Trial management– building the evidence base for decision-making
Enthalten in Trials Bd. 19, 8.1.2018, Nr. 1, date:12.2018: 1-2
|
|
|
|
487 |
Uncovering the emotional aspects of working on a clinical trial: a qualitative study of the experiences and views of staff involved in a type 1 diabetes trial
Enthalten in Trials Bd. 16, 7.1.2015, Nr. 1, date:12.2015: 1-11
|
|
|
|
488 |
Understanding the null hypothesis (H0) in non-inferiority trials
Enthalten in Critical care Bd. 21, 6.5.2017, Nr. 1, date:12.2017: 1-2
|
|
|
|
489 |
Use and Safety of Anthroposophic Medicinal Products: An Analysis of 44,662 Patients from the EvaMed Pharmacovigilance Network
Enthalten in Drugs - real world outcomes Bd. 4, 30.9.2017, Nr. 4, date:12.2017: 199-213
|
|
|
|
490 |
Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: A descriptive study
Enthalten in BMC complementary and alternative medicine Bd. 17, 4.5.2017, Nr. 1, date:12.2017: 1-10
|
|
Administration
